| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |